Zhongzhu Medical Holdings Co Ltd (600568) - Total Liabilities
Based on the latest financial reports, Zhongzhu Medical Holdings Co Ltd (600568) has total liabilities worth CN¥341.90 Million CNY (≈ $50.03 Million USD) as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore Zhongzhu Medical Holdings Co Ltd strategic investment ratio to see how much of total assets are deployed in long-term investments.
Zhongzhu Medical Holdings Co Ltd - Total Liabilities Trend (1998–2025)
This chart illustrates how Zhongzhu Medical Holdings Co Ltd's total liabilities have evolved over time, based on quarterly financial data. For the complete balance sheet picture, see how large is Zhongzhu Medical Holdings Co Ltd's balance sheet.
Zhongzhu Medical Holdings Co Ltd Competitors by Total Liabilities
The table below lists competitors of Zhongzhu Medical Holdings Co Ltd ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
indie Semiconductor Inc
NASDAQ:INDI
|
USA | $519.37 Million |
|
Xingtong Shipping Co. Ltd.
SHG:603209
|
China | CN¥2.19 Billion |
|
Beijing Konruns Pharmaceutical Co Ltd
SHG:603590
|
China | CN¥569.41 Million |
|
CEWE Stiftung & Co. KGaA
XETRA:CWC
|
Germany | €200.76 Million |
|
Daqo New Energy Corp
F:5DQ2
|
Germany | €478.00 Million |
|
Shenyang Jinbei Automotive Co Ltd
SHG:600609
|
China | CN¥2.29 Billion |
|
Beijing North Star Co Ltd Class A
SHG:601588
|
China | CN¥34.01 Billion |
|
Zhejiang Anglikang Pharmaceutical Co Ltd Class A
SHE:002940
|
China | CN¥1.07 Billion |
Liability Composition Analysis (1998–2025)
This chart breaks down Zhongzhu Medical Holdings Co Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. See 600568 equity to assets ratio to measure how much of total assets are equity-financed.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 3.50 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.21 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.18 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Zhongzhu Medical Holdings Co Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Zhongzhu Medical Holdings Co Ltd (1998–2025)
The table below shows the annual total liabilities of Zhongzhu Medical Holdings Co Ltd from 1998 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | CN¥343.56 Million ≈ $50.27 Million |
-9.08% |
| 2024-12-31 | CN¥377.87 Million ≈ $55.29 Million |
-11.79% |
| 2023-12-31 | CN¥428.35 Million ≈ $62.68 Million |
-44.80% |
| 2022-12-31 | CN¥775.97 Million ≈ $113.55 Million |
+6.41% |
| 2021-12-31 | CN¥729.24 Million ≈ $106.71 Million |
+33.70% |
| 2020-12-31 | CN¥545.44 Million ≈ $79.82 Million |
-38.61% |
| 2019-12-31 | CN¥888.46 Million ≈ $130.01 Million |
-34.79% |
| 2018-12-31 | CN¥1.36 Billion ≈ $199.37 Million |
+21.04% |
| 2017-12-31 | CN¥1.13 Billion ≈ $164.71 Million |
+0.05% |
| 2016-12-31 | CN¥1.13 Billion ≈ $164.63 Million |
-31.69% |
| 2015-12-31 | CN¥1.65 Billion ≈ $240.99 Million |
-16.01% |
| 2014-12-31 | CN¥1.96 Billion ≈ $286.93 Million |
+34.12% |
| 2013-12-31 | CN¥1.46 Billion ≈ $213.94 Million |
+19.26% |
| 2012-12-31 | CN¥1.23 Billion ≈ $179.39 Million |
+3.90% |
| 2011-12-31 | CN¥1.18 Billion ≈ $172.65 Million |
-14.61% |
| 2010-12-31 | CN¥1.38 Billion ≈ $202.19 Million |
+83.01% |
| 2009-12-31 | CN¥755.02 Million ≈ $110.48 Million |
-27.76% |
| 2008-12-31 | CN¥1.05 Billion ≈ $152.94 Million |
+28.44% |
| 2007-12-31 | CN¥813.71 Million ≈ $119.07 Million |
-1.79% |
| 2006-12-31 | CN¥828.56 Million ≈ $121.24 Million |
+0.55% |
| 2005-12-31 | CN¥824.06 Million ≈ $120.59 Million |
+192.06% |
| 2004-12-31 | CN¥282.16 Million ≈ $41.29 Million |
+192.35% |
| 2003-12-31 | CN¥96.51 Million ≈ $14.12 Million |
+187.79% |
| 2002-12-31 | CN¥33.54 Million ≈ $4.91 Million |
+24.93% |
| 2001-12-31 | CN¥26.84 Million ≈ $3.93 Million |
-48.38% |
| 2000-12-31 | CN¥52.00 Million ≈ $7.61 Million |
+16.89% |
| 1999-12-31 | CN¥44.49 Million ≈ $6.51 Million |
-2.83% |
| 1998-12-31 | CN¥45.79 Million ≈ $6.70 Million |
-- |
About Zhongzhu Medical Holdings Co Ltd
Zhongzhu Healthcare Holding Co.,Ltd engages in the research and development, production, and sale of drugs in China. The company offers Ophthalmic drugs, including pearl brightening eye drops, clindamycin phosphate for injection, acyclovir dispersible tablets, sodium cromoglycate eye drops, acyclovir for injection, diclofenac sodium suppositories, diclofenac sodium liniment, azithromycin granules… Read more